1. Varied Innovations and Use across Numerous Applications Forming the Crux of Flow Cytometry Market Growth
    Flow cytometry is a technique used to identify and measure certain characteristics of a cell population or particles. Sample cells or particles are inserted in the flow cytometry device.

    Avatar
    Tags
    marketinsight
    markettrends
    By aditi240 il 19 June 2020
     
    0 Comments   27 Views
    .
    Data acquired by the sensors are integrated to construct a comprehensive picture of the sample. The ability of flow cytometry to provide rapid multi-parametric analysis of cells makes it prominent across the cell biology sector. These factors prove to be beneficial aspects for the growth of flow cytometry market across the forecast period of 2020-2025.

    Taking the aforementioned factors into consideration, the analysts at Fact.MR predict that the flow cytometry market may observe a healthy 11.4% CAGR across the forecast period. Fact.MR experts also state that the flow cytometry market shall surpass a valuation of US$ 8.1 bn by the end of the forecast period.

    COVID-19 Outbreak Can Accelerate Growth Rate of Flow Cytometry Market

    Various scientists and researchers are engrossed in research revolving around the novel coronavirus pandemic. The mass cytometry platform is proving to be useful for research and development activities. The use of cytometry to monitor and analyze immune responses to COVID-19 therapeutic approaches may deepen the growth roots of flow cytometry market.

    Technological Advancements Building Foundation of Growth for Flow Cytometry Market

    Flow cytometry techniques are undergoing transformational changes in terms of technology. Manufacturers in the flow cytometry market are leaving no stone unturned in conducting frequent research and development activities. They help in new formulations and technologies that can make the flow cytometry process efficient and profitable.

    Some well-entrenched players in the flow cytometry market are Sysmex Corporation, Becton Dickinson & Company, MiltenyiBiotec, Bio-Rad Laboratories Inc., Beckman Coulter Inc., and Thermo Fisher Scientific Inv.

    Breakthroughs in the flow cytometry market through modern techniques like multicolor flow cytometry are gaining considerable momentum. The use of flow cytometry in various applications is adding the extra stars of growth to the flow cytometry market. Flow cytometry is used to diagnose primary immunodeficiencies through the functional monocyte flow cytometry technique.

    Extensive insights by scientists and researchers are also inviting good growth opportunities for the flow cytometry market. For instance, a research team at Westmead Institute for Medical Research has discovered that flow cytometry may improve transplant outcomes for diabetics. In another development, a research team from the University of Tokyo developed an optomechanics-based imaging method that enables high throughput imaging of single cells. Such developments breathe fresh air of growth in the flow cytometry market.

    Academic and Research Institutions Segment To Acquire the Front Seat for Flow Cytometry Market Growth

    The use of flow cytometry across academic and research institutions across the world may invite exponential growth for the flow cytometry market. This aspect can be confirmed through the healthy 12.1% CAGR estimated to be observed across the forecast period by the academic and research institutions' end-user segment. In terms of revenue, this segment is anticipated to reach a US$ 3.6 bn value at the end of the forecast period.

    Modernization of diagnostic procedures has led to substantial use of flow cytometry in the hospital and diagnostic segment. This end-user segment is estimated to expand at 11% CAGR during the forecast period.

    North America to Clinch Winner Tag for Largest Growth Contribution to Flow Cytometry Market

    The geographical landscape of the flow cytometry market comprises of the Middle East and Africa, North America, Latin America, Europe, and Asia Pacific. North America may gain prominence for contributing massively to the growth of the flow cytometry market. Increasing prevalence of cancer and other chronic condition-related incidences and the presence of major pharmaceuticals in the U.S. may serve as prime factors for the growth of the flow cytometry market.

    Asia Pacific may also record stable growth across the forecast period. Large-scale research and development activities related to COVID-19 and other diseases in the region are significantly influencing the growth rate. Other factors such as focus on developing a modern healthcare infrastructure and a considerable increase in demand for early diagnosis of various diseases and infections may prove to be growth generators for the flow cytometry market.
      Share  
     
    .